D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 44 Citations 10,220 111 World Ranking 11006 National Ranking 833

Overview

What is he best known for?

The fields of study he is best known for:

  • Organic chemistry
  • Enzyme
  • Catalysis

The scientist’s investigation covers issues in Stereochemistry, Factor Xa Inhibitor, Protease, Copper and Enzyme. His biological study spans a wide range of topics, including Proteases, Group, Salt, Structure–activity relationship and Enzyme inhibitor. His Factor Xa Inhibitor research incorporates elements of Pyrazole, Thrombin and Benzamidine.

His work carried out in the field of Pyrazole brings together such families of science as Bicyclic molecule and Carboxamide. His Copper study combines topics in areas such as Polymer chemistry and Coupling reaction. His research investigates the connection between Enzyme and topics such as Anticoagulant Agent that intersect with problems in Discovery and development of direct thrombin inhibitors.

His most cited work include:

  • Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors (704 citations)
  • New aryl/heteroaryl CN bond cross-coupling reactions via arylboronic acid/cupric acetate arylation (701 citations)
  • Copper-Promoted Carbon-HeteroatomBond Cross-Coupling with Boronic Acids and Derivatives (349 citations)

What are the main themes of his work throughout his whole career to date?

Patrick Y.S. Lam mainly focuses on Stereochemistry, Factor Xa Inhibitor, Protease, Pharmacology and Enzyme inhibitor. His Stereochemistry study combines topics from a wide range of disciplines, such as Structure–activity relationship, Chemical synthesis and Enzyme. His Factor Xa Inhibitor research is multidisciplinary, incorporating perspectives in Lactam, Salt, Guanidine and Carboxamide.

His Protease research is multidisciplinary, incorporating elements of Urea and Virus. His work on Bioavailability as part of general Pharmacology study is frequently linked to Fibrinolytic agent, bridging the gap between disciplines. His Enzyme inhibitor research includes elements of Benzamidine, Amidine, Molecular model and Thrombin.

He most often published in these fields:

  • Stereochemistry (43.35%)
  • Factor Xa Inhibitor (31.79%)
  • Protease (16.18%)

What were the highlights of his more recent work (between 2010-2020)?

  • Pharmacology (16.18%)
  • Stereochemistry (43.35%)
  • Antithrombotic (8.67%)

In recent papers he was focusing on the following fields of study:

Pharmacology, Stereochemistry, Antithrombotic, Combinatorial chemistry and Bioavailability are his primary areas of study. His work on Pharmacokinetics as part of general Pharmacology research is frequently linked to In vivo, thereby connecting diverse disciplines of science. In his research, he undertakes multidisciplinary study on Stereochemistry and P2y1 receptor.

His Antithrombotic research is multidisciplinary, relying on both P2Y12, Antagonist, Coagulation, Thrombus and Drug discovery. His Combinatorial chemistry study integrates concerns from other disciplines, such as Factor XIa, Structure–activity relationship, Imidazole and Enzyme. Many of his studies on Bioavailability involve topics that are commonly interrelated, such as Factor Xa Inhibitor.

Between 2010 and 2020, his most popular works were:

  • Copper-Promoted Carbon-HeteroatomBond Cross-Coupling with Boronic Acids and Derivatives (349 citations)
  • Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor (57 citations)
  • Conformationally Constrained ortho-Anilino Diaryl Ureas: Discovery of 1-(2-(1′-Neopentylspiro[indoline-3,4′-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a Potent, Selective, and Bioavailable P2Y1 Antagonist (40 citations)

In his most recent research, the most cited papers focused on:

  • Organic chemistry
  • Enzyme
  • Catalysis

His primary areas of study are Pharmacology, Stereochemistry, Antithrombotic, Factor XIa and Combinatorial chemistry. His studies in Pharmacology integrate themes in fields like Clotting time and Potency. Patrick Y.S. Lam combines subjects such as Selectivity and Bioavailability with his study of Stereochemistry.

His study focuses on the intersection of Antithrombotic and fields such as Antagonist with connections in the field of Piperidine, Indoline, Lead compound, Urea and Platelet. His Combinatorial chemistry study incorporates themes from Carbon, Chemical synthesis, Chemical coupling and Reaction mechanism. His work deals with themes such as Chan-Lam coupling, Coupling reaction and Copper, which intersect with Chemical coupling.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

New aryl/heteroaryl CN bond cross-coupling reactions via arylboronic acid/cupric acetate arylation

Patrick Y.S Lam;Charles G Clark;Simon Saubern;Jessica Adams.
Tetrahedron Letters (1998)

1105 Citations

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

PY Lam;PK Jadhav;CJ Eyermann;CN Hodge.
Science (1994)

1074 Citations

Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa.

Donald J.P. Pinto;Michael J. Orwat;Stephanie Koch;Karen A. Rossi.
Journal of Medicinal Chemistry (2007)

534 Citations

Copper-Promoted Carbon-HeteroatomBond Cross-Coupling with Boronic Acids and Derivatives

Jennifer X. Qiao;Patrick Y. S. Lam.
Synthesis (2011)

533 Citations

Copper-catalyzed general CN and CO bond cross-coupling with arylboronic acid

Patrick Y.S Lam;Guillaume Vincent;Charles G Clark;Sophie Deudon.
Tetrahedron Letters (2001)

401 Citations

Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies.

P. C. Wong;E. J. Crain;B. Xin;R. R. Wexler.
Journal of Thrombosis and Haemostasis (2008)

386 Citations

Flexibility and function in HIV-1 protease

Linda K. Nicholson;Toshimasa Yamazaki;Dennis A. Torchia;Stephan Grzesiek.
Nature Structural & Molecular Biology (1995)

301 Citations

Lactam-containing compounds and derivatives thereof as factor xa inhibitors

Donald J.P. Pinto;Mimi L. Quan;Michael J. Orwat;Yun-Long Li.
(2002)

288 Citations

Copper-Promoted C−N Bond Cross-Coupling with Hypervalent Aryl Siloxanes and Room-Temperature N-Arylation with Aryl Iodide

Patrick Y. S. Lam;Sophie Deudon;Kristin M. Averill;Renhua Li.
Journal of the American Chemical Society (2000)

255 Citations

Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa.

Donald J. P. Pinto;Michael J. Orwat;Shuaige Wang;John M. Fevig.
Journal of Medicinal Chemistry (2001)

249 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Patrick Y. S. Lam

John M. Louis

John M. Louis

National Institutes of Health

Publications: 27

Stephen L. Buchwald

Stephen L. Buchwald

MIT

Publications: 16

Gerhard Klebe

Gerhard Klebe

Philipp University of Marburg

Publications: 15

Paul G. Mezey

Paul G. Mezey

Memorial University of Newfoundland

Publications: 15

Ernesto Freire

Ernesto Freire

Johns Hopkins University

Publications: 15

Gregory Y.H. Lip

Gregory Y.H. Lip

University of Liverpool

Publications: 13

Celia A. Schiffer

Celia A. Schiffer

University of Massachusetts Medical School

Publications: 12

J. Andrew McCammon

J. Andrew McCammon

University of California, San Diego

Publications: 12

M. Lakshmi Kantam

M. Lakshmi Kantam

Indian Institute of Chemical Technology

Publications: 11

Anders Hallberg

Anders Hallberg

Uppsala University

Publications: 11

Jeffrey I. Weitz

Jeffrey I. Weitz

McMaster University

Publications: 11

Michael K. Gilson

Michael K. Gilson

University of Montana

Publications: 11

Mats Larhed

Mats Larhed

Uppsala University

Publications: 10

Dennis A. Torchia

Dennis A. Torchia

National Institutes of Health

Publications: 10

Shannon S. Stahl

Shannon S. Stahl

University of Wisconsin–Madison

Publications: 10

Paul T. Wingfield

Paul T. Wingfield

National Institutes of Health

Publications: 9

Trending Scientists

Roland Badeau

Roland Badeau

Télécom ParisTech

Samuel Williams

Samuel Williams

Lawrence Berkeley National Laboratory

Mostafa Fatemi

Mostafa Fatemi

Mayo Clinic

Xiaolin Xie

Xiaolin Xie

Huazhong University of Science and Technology

Koji Otsuka

Koji Otsuka

Kyoto University

Patrick Concannon

Patrick Concannon

University of Florida

Guillermo Gosset

Guillermo Gosset

National Autonomous University of Mexico

Anna-Lise Williamson

Anna-Lise Williamson

University of Cape Town

Anja Miltner

Anja Miltner

Helmholtz Centre for Environmental Research

Nadine Gobron

Nadine Gobron

Joint Research Centre

Martin Zeitz

Martin Zeitz

Charité - University Medicine Berlin

Michael J. Chandler

Michael J. Chandler

University of British Columbia

Lionel H. Opie

Lionel H. Opie

University of Cape Town

Thomas M. Gress

Thomas M. Gress

Philipp University of Marburg

Lianjiang Li

Lianjiang Li

Lingnan University

Morris Janowitz

Morris Janowitz

University of Chicago

Something went wrong. Please try again later.